NASDAQ: RVPH
Reviva Pharmaceuticals Holdings Inc Stock Ownership - Who owns Reviva Pharmaceuticals Holdings?

Insider buying vs selling

Have Reviva Pharmaceuticals Holdings Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RVPH insiders and whales buy or sell their stock.

RVPH Shareholders

What type of owners hold Reviva Pharmaceuticals Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc24.96%3,197,581$2.72MInstitution
Laxminarayan Bhat19.39%2,484,244$2.11MInsider
Millennium Management LLC17.67%2,263,470$1.92MInstitution
Tenzing LLC16.56%2,121,750$1.80MInsider
Rahul Nayar15.02%1,924,250$1.64MInsider
Parag Saxena15.02%1,924,250$1.64MInsider
Geode Capital Management LLC8.19%1,048,954$891.61kInstitution
Glazer Capital LLC7.94%1,017,000$864.45kInsider
Jane Street Group LLC6.98%894,749$760.54kInstitution
Mizuho Securities Usa LLC 16.38%817,750$695.09kInsider

1 of 3

RVPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RVPH51.46%48.54%
GTBP1.53%3.82%
BIVI2.37%97.63%
GDTC0.45%56.05%
HOTH6.07%49.70%Net Selling

Reviva Pharmaceuticals Holdings Stock Ownership FAQ

Who owns Reviva Pharmaceuticals Holdings?

Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) is owned by 88.39% institutional shareholders, 83.37% Reviva Pharmaceuticals Holdings insiders, and 0.00% retail investors. Laxminarayan Bhat is the largest individual Reviva Pharmaceuticals Holdings shareholder, owning 2.48M shares representing 19.39% of the company. Laxminarayan Bhat's Reviva Pharmaceuticals Holdings shares are currently valued at $2.26M.

If you're new to stock investing, here's how to buy Reviva Pharmaceuticals Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.